PRTC(Delisted)
Puretech Health (PRTC) Stock Statistics, Valuation & Financial Metrics
Total Valuation
Puretech Health market cap is -- and enterprise value is --.
Share Statistics
Puretech Health has 24.34M shares outstanding, with a free float of --.
Valuation Ratios
Puretech Health's PE ratio is --, PB ratio is --, and PS ratio is --, showing whether the stock looks expensive or cheap.
Solvency
Puretech Health debt-to-equity ratio is 0.02 and debt-to-assets ratio is 0.43.
Liquidity
Puretech Health's current ratio is 6.59, quick ratio is 6.59, and cash ratio is 6.27, showing its short-term liquidity position.
Return on Capital
Puretech Health's ROE is -30.20%, ROA is -19.36%, and ROIC is -27.04%, showing its return on capital profile.
Profitability
Puretech Health gross margin is 100.00%, operating margin is -2114.75%, and net margin is -2362.82%.
Cost Structure
Puretech Health spends 1214.14% of revenue on R&D and 1000.60% on SG&A.
Operating Efficiency
Puretech Health's asset turnover is 0.01, inventory turnover is --, and receivables turnover is 2.84, indicating its operating efficiency.
Income Statement
Puretech Health's revenue is 4.66M, gross profit is 4.66M, net income is -110.08M, and EBITDA is -95.18M.
Balance Sheet
Puretech Health's total debt is 4.92M, net debt is -285.40M, total equity is 312.07M, and cash is 290.31M.
Cash Flow Statement
Puretech Health's operating cash flow is -85.13M, free cash flow is -85.14M, and CapEx is -6.00K.
Dividends & Yields
Puretech Health dividend yield is --, with a payout ratio of -- and dividend per share of --.
Analyst Rating
Puretech Health's latest analyst rating is Unrate, with an analyst target price of --.
Company Info
A clinical-stage biotherapeutics company that develops products based on insights into the biology of the brain, immune, and gut systems
Per Share Metrics
Puretech Health's EPS is -4.6, book value per share is 12.91, and free cash flow per share is -3.52.
